00718-A: Ras Mutations in Canine Lymphoid and Myeloid Leukemias

Grant Status: Closed

Grant Amount: $10,800
Laura Blackwood, PhD; University of Liverpool
March 1, 2006 - February 28, 2007


Breed(s): -All Dogs
Research Program Area: Oncology
Donate to Support this Research Program Area


Ras is the most frequently mutated oncogene in human cancer, and ras mutations are seen in up to 20 percent of patients with acute lymphoid leukemia, and 20-44 percent of patients with acute myeloid leukaemia. These mutations provide a proliferative signal by activation of the RTK/ras signalling pathways, and in human patients the presence or absence of these mutations is associated with prognosis and chemosensitivity. The molecular genetics of canine leukemia are undefined. We hypothesize that ras mutations are likely to occur in canine leukemias and our objective is to identify and characterize these mutations and determine their frequency and significance.


Usher, S. G., Radford, A. D., Villiers, E. J., & Blackwood, L. (2009). RAS, FLT3, and C-KIT mutations in immunophenotyped canine leukemias. Experimental Hematology, 37(1), 65–77. https://doi.org/10.1016/j.exphem.2008.09.005

Help Future Generations of Dogs

Participate in canine health research by providing samples or by enrolling in a clinical trial. Samples are needed from healthy dogs and dogs affected by specific diseases.

Learn How to Help

Make an Investment Today:

  • $50
  • $100
  • $250
  • $1000
  • Give Now
Connect With Us:
Get Canine Health News:
Please leave this field empty

© 2018 AKC Canine Health Foundation | Privacy Policy | Site Map

Site by Blackbaud, Inc.

Powered by Blackbaud
nonprofit software